Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings, Inc. (DNA)
:DNA
DNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.00 - $16.85
Previous CloseN/A
Volume618.97K
Average Volume (3M)1.61M
Market Cap
$763.68M
Enterprise Value$561.35M
Total Cash (Recent Filing)$473.69M
Total Debt (Recent Filing)$428.83M
Price to Earnings (P/E)―
Beta2.94
Next Earnings
Nov 17, 2025EPS Estimate
-1.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding47,089,600
10 Day Avg. Volume1,638,518
30 Day Avg. Volume1,608,964
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue2.43
Enterprise Value/Gross Profit2.96
Enterprise Value/Ebitda-1.80
Forecast
1Y Price Target
$10.70Price Target Upside-17.05% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted EBITDA: Loss of $28 million beat the estimated $49.0 million loss.
Operational GrowthCell Engineering beat as active program count grew 10% year-over-year, benefiting from Ginkgo’s broader menu of offerings.
Strategic ExpansionGinkgo could see potential upside to estimates driven by continued expansion into AI tools and data-driven offerings alongside additional opportunities in their biosecurity pipeline.
Bears Say
Leadership ChangesCFO Mark Dmytruk is resigning from his role to pursue a new role at a different company.
Market SentimentAnalyst's visibility on revenue per program remains low, leading to a reiteration of a Sell rating and a $6 price target for shares of DNA.
Revenue ChallengesBiosecurity revenues saw a 48% year-over-year drop due to delays on international contracts.
Ginkgo Bioworks Holdings News
DNA FAQ
What was Ginkgo Bioworks Holdings, Inc.’s price range in the past 12 months?
Ginkgo Bioworks Holdings, Inc. lowest stock price was $5.00 and its highest was $16.85 in the past 12 months.
What is Ginkgo Bioworks Holdings, Inc.’s market cap?
Ginkgo Bioworks Holdings, Inc.’s market cap is $763.68M.
When is Ginkgo Bioworks Holdings, Inc.’s upcoming earnings report date?
Ginkgo Bioworks Holdings, Inc.’s upcoming earnings report date is Nov 17, 2025 which is in 93 days.
How were Ginkgo Bioworks Holdings, Inc.’s earnings last quarter?
Ginkgo Bioworks Holdings, Inc. released its earnings results on Aug 07, 2025. The company reported -$1.1 earnings per share for the quarter, beating the consensus estimate of -$1.567 by $0.467.
Is Ginkgo Bioworks Holdings, Inc. overvalued?
According to Wall Street analysts Ginkgo Bioworks Holdings, Inc.’s price is currently Overvalued.
Does Ginkgo Bioworks Holdings, Inc. pay dividends?
Ginkgo Bioworks Holdings, Inc. does not currently pay dividends.
What is Ginkgo Bioworks Holdings, Inc.’s EPS estimate?
Ginkgo Bioworks Holdings, Inc.’s EPS estimate is -1.41.
How many shares outstanding does Ginkgo Bioworks Holdings, Inc. have?
Ginkgo Bioworks Holdings, Inc. has 47,089,600 shares outstanding.
What happened to Ginkgo Bioworks Holdings, Inc.’s price movement after its last earnings report?
Ginkgo Bioworks Holdings, Inc. reported an EPS of -$1.1 in its last earnings report, beating expectations of -$1.567. Following the earnings report the stock price went down -8.692%.
Which hedge fund is a major shareholder of Ginkgo Bioworks Holdings, Inc.?
Currently, no hedge funds are holding shares in DNA
Ginkgo Bioworks Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$10.70 (-17.05% Downside)
$10.70 (-17.05% Downside)
Blogger Sentiment
Neutral
DNA Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 26.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.41%
12-Months-Change
Fundamentals
Return on Equity
-43.59%
Trailing 12-Months
Asset Growth
-24.26%
Trailing 12-Months
Company Description
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
DNA Company Deck
DNA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant improvements in cost reduction and financial metrics, along with successful product launches. However, challenges remain with lowered revenue guidance in the biosecurity segment and ongoing operating losses. The company is strategically positioned for future growth, especially in automation and life science tools.View all DNA earnings summariesDNA Revenue Breakdown
57.08% Cell Engineering
42.92% Biosecurity
DNA Stock 12 Month Forecast
Average Price Target
$10.70
▼(-17.05% Downside)
Technical Analysis
Sana Biotechnology
―
Tourmaline Bio
―
Erasca
―
Rapport Therapeutics, Inc.
―
Maze Therapeutics, Inc.
―
Ownership Overview
1.07% Insiders
14.87% Mutual Funds
32.58% Other Institutional Investors
37.52% Public Companies and Individual Investors